new glp 1 coming to market GLP-1 Trends and Global Forecasts Report 2025: A GLP-1 Receptor Agonist Market Size

Dosing Errors May Be More Common With Compounded GLP-1s Multiple adverse event reports were related to dosing mistakes with compounded semaglutide injections, which resulted from patients self-administering incorrect doses or healthcare providers miscalculating doses, the FDA said

This is not a theoretical problem

They're addicted to rebates

Until this past year, there was a lack of any literature reporting on the perioperative risk profile for patients who take GLP-1 agonists before surgery and the impact on surgical outcomes

That said, these effects are only observed when the medication is prescribed appropriately and used in combination with provider-guided lifestyle support